A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Consolidated Statement of Cash Flows for the year ended 31 December Cash flows from operating activities Profit before tax Finance income and expense Share of after tax losses in associates and joint ventures Depreciation, amortisation and impairment Increase in trade and other receivables Increase in inventories Increase in trade and other payables and provisions Gains on disposal of intangible assets Fair value movements on contingent consideration arising from business combinations Non-cash and other movements Cash generated from operations Interest paid Tax paid Net cash inflow from operating activities Cash flows from investing activities Acquisition of subsidiaries, net of cash acquired Payments upon vesting of employee share awards attributable to business combinations Payment of contingent consideration from business combinations Purchase of property, plant and equipment Disposal of property, plant and equipment Purchase of intangible assets Disposal of intangible assets Moveme
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 58.7B | 58.7B | 54.1B | 45.8B | 44.4B | 37.4B |
| Net Income | 10.2B | 10.2B | 7.0B | 6.0B | 3.3B | 115M |
| EPS | $13.08 | $13.08 | $9.00 | $7.62 | $4.22 | $0.16 |
| Free Cash Flow | 11.8B | 11.8B | 9.9B | 9.0B | 8.7B | 6.0B |
| ROIC | 16.0% | 16.8% | 13.5% | 12.9% | 6.2% | 1.7% |
| Gross Margin | 81.9% | 81.9% | 81.1% | 82.0% | 72.1% | 66.8% |
| Debt/Equity | 0.57 | 0.57 | 0.71 | 0.57 | 0.76 | 0.72 |
| Dividends/Share | $6.35 | $6.35 | $5.92 | $5.73 | $5.59 | - |
| Operating Income | 13.7B | 13.7B | 10.0B | 8.2B | 3.8B | 1.1B |
| Operating Margin | 23.4% | 23.4% | 18.5% | 17.9% | 8.5% | 2.8% |
| ROE | 21.0% | 22.8% | 17.6% | 15.6% | 8.6% | 0.3% |
| Shares Outstanding | 782M | 782M | 782M | 782M | 780M | 719M |
ASTRAZENECA PLC passes 6 of 9 quality checks, suggesting mixed fundamentals.
ASTRAZENECA PLC trades at 22.5x trailing earnings, compared to its 15-year median P/E of 17.3x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 15.9x vs a median of 11.2x. The company's 5-year average ROIC is 10.2% with a gross margin of 76.8%. Total shareholder yield (dividends) is 3.1%. At current prices, the estimated annualized return to fair value is +26.8%.
ASTRAZENECA PLC (AZN) has a current P/E ratio of 22.5, compared to its historical median P/E of 17.3. The stock is currently considered Fair based on its historical valuation range.
ASTRAZENECA PLC (AZN) has a 5-year average return on invested capital (ROIC) of 10.2%. This indicates solid capital allocation.
ASTRAZENECA PLC (AZN) has a market capitalization of $158.2B. It is classified as a large-cap stock.
Yes, ASTRAZENECA PLC (AZN) pays a dividend with a trailing twelve-month yield of 3.14%.
Based on historical P/E analysis, ASTRAZENECA PLC (AZN) appears fair. The current P/E of 22.5 is 30% above its historical median of 17.3. The estimated fair value CAGR (P/E method) is 19.5%.
ASTRAZENECA PLC (AZN) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
ASTRAZENECA PLC (AZN) reported annual revenue of $58.7 billion in its most recent fiscal year, based on SEC EDGAR filings.
ASTRAZENECA PLC (AZN) has a net profit margin of 17.4%. This is a healthy margin.
ASTRAZENECA PLC (AZN) generated $11.8 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
ASTRAZENECA PLC (AZN) has a debt-to-equity ratio of 0.57. This indicates moderate leverage.
ASTRAZENECA PLC (AZN) reported earnings per share (EPS) of $13.08 in its most recent fiscal year.
ASTRAZENECA PLC (AZN) has a return on equity (ROE) of 22.8%. This indicates the company generates strong returns for shareholders.
ASTRAZENECA PLC (AZN) has a 5-year average gross margin of 76.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 11 years of financial data for ASTRAZENECA PLC (AZN), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ASTRAZENECA PLC (AZN) has a book value per share of $62.27, based on its most recent annual SEC filing.